Abstract
The invention relates to compounds of formula (I): (I) and salts, solvates, tautomers and stereoisomers thereof, where the definitions of the variables are provided herein. The invention also relates to pharmaceutical compositions comprising compounds of formula (I) as well as for the use of such compounds as tankyrase inhibitors and for the treatment of diseases such as cancer.
| Original language | English |
|---|---|
| Patent number | WO2018046933 |
| IPC | A61P35/00,A61K31/47,A61K31/517,A61P3/10,C07D403/12 |
| Priority date | 8/09/16 |
| Publication status | Published - 15 Mar 2018 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'TANKYRASE INHIBITORS'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS